Financing
INOVIO prices a $75 million stock and warrant offering
DNA-medicine developer INOVIO set the price of an underwritten offering of common shares at $1.05 each, alongside pre-funded warrants, for gross proceeds of about $75 million. Closing is expected around November 9, and underwriters can buy roughly 10.7 million more shares within 30 days.
Written by Gosset from public sources. Source types: Press release. Sources are available to Gosset users. Log in to see them.